FDA Worries About Stem Cell Trials
Tomorrow the FDA begins a two-day hearing involving stem cell research and human trials. Monya Baker of Nature magazine's stem cell blog, The Niche, has some insights into the session. Among other things, she writes,
"The FDA is mainly worried that the animal tests used to assess safety problems aren’t good enough and that they won’t know until too late …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.